Category: Providers

Humana Seeks Dismissal of Medicare Advantage 340B Underpayment Suit by Health System

April 16, 2024 Rich Daly, Editor in Chief Views

Humana has asked a federal district judge to dismiss a health system's lawsuit alleging the company's MA plans underpaid for 340B drugs.

Humana asked a federal judge to dismiss Baptist Health of Alabama’s lawsuit against the company’s Medicare Advantage (MA) plans for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

MedPAC Analysis Estimates Medicare Part B Payments to 340B Hospitals are Significantly Higher than Ceiling Prices

April 16, 2024 Shannon Young, Associate Editor/Senior Writer Views

A MedPAC analysis found that Medicare paid 340B hospitals significantly more than the ceiling price for dozens of medications in 2022.

Medicare paid hospitals substantially more—almost $4 billion in aggregate—than the 340B ceiling price costs for dozens of single-source drugs, biologics [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

White House Completes Review of Final Rule for 340B Dispute Process, Release Expected Soon

April 11, 2024 Rich Daly, Editor in Chief Views

The Department of Health and Human Services is expected to soon release its final 340B administrative dispute resolution rule after the White House completed its final review this week.

After missing its self-imposed deadline of the end of 2023, the White House this week completed its review to implement [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Survey Finds FQHC Prescribers May Need More Education on 340B Program

April 11, 2024 Shannon Young, Associate Editor/Senior Writer Views

A survey published in the American Journal of Health-System Pharmacy found some FQHC prescribers need more information on the 340B program.

Prescribers who work in federally qualified health centers (FQHCs) believe the 340B program helps their organizations and patients—even if they [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Teva Adds Blood Therapy Drug to Hospital Contract Pharmacy Restrictions

April 9, 2024 Shannon Young, Associate Editor/Senior Writer Views

Drugmaker Teva has added a blood therapy medication to its existing contract pharmacy restrictions for 340B hospitals.

Drug manufacturer Teva this week added a blood therapy medication to its hospital contract pharmacy restrictions implemented last summer. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospitals Raise Concerns on Biden Drug Shortage Proposal

April 9, 2024 Rich Daly, Editor in Chief Views

HHS recently released a proposal to address drug shortages with measures focused on both hospitals and drug manufacturers.

While the Biden administration’s proposal to address drug shortages does not exempt certain drug products from 340B pricing like the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Tennessee Bill Targeting 340B In-Kind Funding Heads to Governor’s Desk

April 4, 2024 Shannon Young, Associate Editor/Senior Writer Views

The Tennessee legislature cleared a bill, by state Rep. Esther Helton-Haynes (R), that tightens requirements for 340B in-kind funding for STD clinics.

Sexually transmitted disease (STD) clinics in Tennessee may soon have to enter into contracts to receive 340B in-kind funding—and for-profit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Stakeholders Clash on Patient Definition, 340B Spending Requirements in Comments on Senate ‘Group of Six’ Draft Overhaul

April 4, 2024 William Newton, Associate Editor/Senior Writer Views

Advocacy groups for providers and drugmakers had diverging views in their comments on a draft Senate 340B overhaul.

Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospitals Say HRSA Violated Federal Rulemaking in 340B Child Site Waiver Reversal

April 4, 2024 Rich Daly, Editor in Chief Views

More than 40 health systems told a federal district court that a HRSA hospital offsite clinic registration policy reversal violated federal rulemaking requirements.

The dozens of health systems suing the federal government over the reversal of a pandemic-era 340B child site registration waiver [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genentech Officially Issues Contract Pharmacy Restrictions

April 4, 2024 Rich Daly, Editor in Chief Views

Pharmaceutical manufacturer Genentech has formally implemented 340B contract pharmacy restrictions for hospitals.

Drugmaker Genentech has formally issued contract pharmacy restrictions after it gave some 340B hospitals advance notice last month of its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live